Ingredient Safety Concerns Rise Among FDA Enforcement Priorities
This article was originally published in The Tan Sheet
Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.
You may also be interested in...
FDA proposed “a pretty crazy” NDI notification draft guidance, says attorney Wes Siegner, because “they think everything is an NDI.” Other stakeholders acknowledge FDA wants tighter regulation of the industry, but say writing and imposing rules for supplement manufacturing is a two-way street.
Monster Energy products will transition from supplement to conventional food labeling, in a sign that industry may be adapting to FDA’s draft guidance on liquid supplements that stirred controversy upon its publication in 2009.
The HHS Office of the Inspector General finds a number of issues with supplement structure/function claims, and makes several recommendations to FDA to reduce illegal claims and weak substantiation.